Back
Sage Therapeutics Stock Price Chart

Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.
Sell
34
SAGE
Sage Therapeutics
Last Price:
$6.84
Seasonality Move:
-6.91%
7 Day Trial
ALL ACCESS PASS
$
7

Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.-
The current trend is relatively stagnant and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Sage Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.6 | Buy |
20-day SMA: | 6.66 | Buy |
50-day SMA: | 7.1 | Sell |
200-day SMA: | 6.94 | Sell |
8-day EMA: | 6.67 | Buy |
20-day EMA: | 6.74 | Buy |
50-day EMA: | 6.97 | Sell |
200-day EMA: | 8.36 | Sell |
Sage Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 51.14 | Buy |
Chaikin Money Flow: | 510749 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.48 - 6.96) | Buy |
Bollinger Bands (100): | (6.73 - 7.77) | Sell |
Sage Therapeutics Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sage Therapeutics Stock
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 6.85 while SAGE 8-day simple moving average is 6.60, which is a Buy signal.
-
The stock price of SAGE is 6.85 while Sage Therapeutics 20-day SMA is 6.66, which makes it a Buy.
-
Sage Therapeutics 50-day simple moving average is 7.10 while SAGE share price is 6.85, making it a Sell technically.
-
SAGE stock price is 6.85 and Sage Therapeutics 200-day simple moving average is 6.94, creating a Sell signal.
SAGE Technical Analysis vs Fundamental Analysis
Sell
34
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy or a Sell?
-
Sage Therapeutics stock is rated a SellThe current Sage Therapeutics [SAGE] share price is $6.85. The Score for SAGE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Sage Therapeutics Stock Info
Market Cap:
429M
Price in USD:
6.85
Share Volume:
772.7K
Sage Therapeutics 52-Week Range
52-Week High:
13.47
52-Week Low:
4.62
Sell
34
Sage Therapeutics (SAGE)
is a Sell
Sage Therapeutics Share Price Forecast
-
What is the Sage Therapeutics stock price today?The Sage Therapeutics stock price is 6.85 USD today.
-
Will SAGE stock go up or go down?Sage Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sage Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sage Therapeutics is overvalued.
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 6.85 while SAGE 8-day exponential moving average is 6.67, which is a Buy signal.
-
The stock price of SAGE is 6.85 while Sage Therapeutics 20-day EMA is 6.74, which makes it a Buy.
-
Sage Therapeutics 50-day exponential moving average is 6.97 while SAGE share price is 6.85, making it a Sell technically.
-
SAGE stock price is 6.85 and Sage Therapeutics 200-day simple moving average is 8.36, creating a Sell signal.
Fundamental Analysis of Sage Therapeutics
Is Sage Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.42 per share, an increase this year of $2.76 per share, and an increase next year of $0.46 per share.
Technical Analysis of Sage Therapeutics
Should I short Sage Therapeutics stock?
-
SAGE Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Sage Therapeutics is a Sell
-
Sage Therapeutics Relative Strength Index (RSI) is 51.14, which suggest Sage Therapeutics is overbought
-
The Bollinger Bands (25) for Sage Therapeutics is (6.48 - 6.96), which suggest Sage Therapeutics is a Sell
-
The Bollinger Bands (100) for Sage Therapeutics is (6.73 - 7.77), which suggest Sage Therapeutics is a Sell
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.